K203193: BD Intraosseous Infusion System (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K203193 (BD Intraosseous Infusion System, cleared 2021-03-04 for Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K203193 |
| Cleared Device Trade / Generic Name | BD Intraosseous Infusion System |
| FDA Applicant on Filing | Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd] |
| FDA 3-Letter Product Classification | Product Code MHC |
| FDA Substantial Equivalence Decision Date | 2021-03-04 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.
Inspect consolidated manufacturer lineage at Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd], compare peer devices under FDA Product Code MHC, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.